Cargando…
FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator
Frontotemporal dementia and/or amyotrophic lateral sclerosis type 7 (FTD/ALS7) is an autosomal dominant neurodegenerative disorder characterized by the onset of FTD and/or ALS, mainly in adulthood. Patients with some types of mutations, including the Thr104Asn (T104N) mutation of charged multivesicu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443297/ https://www.ncbi.nlm.nih.gov/pubmed/37606396 http://dx.doi.org/10.3390/neurolint15030063 |
_version_ | 1785093796291149824 |
---|---|
author | Shirai, Remina Cho, Mizuka Isogai, Mikinori Fukatsu, Shoya Okabe, Miyu Okawa, Maho Miyamoto, Yuki Torii, Tomohiro Yamauchi, Junji |
author_facet | Shirai, Remina Cho, Mizuka Isogai, Mikinori Fukatsu, Shoya Okabe, Miyu Okawa, Maho Miyamoto, Yuki Torii, Tomohiro Yamauchi, Junji |
author_sort | Shirai, Remina |
collection | PubMed |
description | Frontotemporal dementia and/or amyotrophic lateral sclerosis type 7 (FTD/ALS7) is an autosomal dominant neurodegenerative disorder characterized by the onset of FTD and/or ALS, mainly in adulthood. Patients with some types of mutations, including the Thr104Asn (T104N) mutation of charged multivesicular body protein 2B (CHMP2B), have predominantly ALS phenotypes, whereas patients with other mutations have predominantly FTD phenotypes. A few mutations result in patients having both phenotypes approximately equally; however, the reason why phenotypes differ depending on the position of the mutation is unknown. CHMP2B comprises one part of the endosomal sorting complexes required for transport (ESCRT), specifically ESCRT-III, in the cytoplasm. We describe here, for the first time, that CHMP2B with the T104N mutation inhibits neuronal process elongation in the N1E-115 cell line, a model line undergoing neuronal differentiation. This inhibitory phenotype was accompanied by changes in marker protein expression. Of note, CHMP2B with the T104N mutation, but not the wild-type form, was preferentially accumulated in the Golgi body. Of the four major Golgi stress signaling pathways currently known, the pathway through Arf4, the small GTPase, was specifically upregulated in cells expressing CHMP2B with the T104N mutation. Conversely, knockdown of Arf4 with the cognate small interfering (si)RNA recovered the neuronal process elongation inhibited by the T104N mutation. These results suggest that the T104N mutation of CHMP2B inhibits morphological differentiation by triggering Golgi stress signaling, revealing a possible therapeutic molecular target for recovering potential molecular and cellular phenotypes underlying FTD/ALS7. |
format | Online Article Text |
id | pubmed-10443297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104432972023-08-23 FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator Shirai, Remina Cho, Mizuka Isogai, Mikinori Fukatsu, Shoya Okabe, Miyu Okawa, Maho Miyamoto, Yuki Torii, Tomohiro Yamauchi, Junji Neurol Int Article Frontotemporal dementia and/or amyotrophic lateral sclerosis type 7 (FTD/ALS7) is an autosomal dominant neurodegenerative disorder characterized by the onset of FTD and/or ALS, mainly in adulthood. Patients with some types of mutations, including the Thr104Asn (T104N) mutation of charged multivesicular body protein 2B (CHMP2B), have predominantly ALS phenotypes, whereas patients with other mutations have predominantly FTD phenotypes. A few mutations result in patients having both phenotypes approximately equally; however, the reason why phenotypes differ depending on the position of the mutation is unknown. CHMP2B comprises one part of the endosomal sorting complexes required for transport (ESCRT), specifically ESCRT-III, in the cytoplasm. We describe here, for the first time, that CHMP2B with the T104N mutation inhibits neuronal process elongation in the N1E-115 cell line, a model line undergoing neuronal differentiation. This inhibitory phenotype was accompanied by changes in marker protein expression. Of note, CHMP2B with the T104N mutation, but not the wild-type form, was preferentially accumulated in the Golgi body. Of the four major Golgi stress signaling pathways currently known, the pathway through Arf4, the small GTPase, was specifically upregulated in cells expressing CHMP2B with the T104N mutation. Conversely, knockdown of Arf4 with the cognate small interfering (si)RNA recovered the neuronal process elongation inhibited by the T104N mutation. These results suggest that the T104N mutation of CHMP2B inhibits morphological differentiation by triggering Golgi stress signaling, revealing a possible therapeutic molecular target for recovering potential molecular and cellular phenotypes underlying FTD/ALS7. MDPI 2023-08-11 /pmc/articles/PMC10443297/ /pubmed/37606396 http://dx.doi.org/10.3390/neurolint15030063 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shirai, Remina Cho, Mizuka Isogai, Mikinori Fukatsu, Shoya Okabe, Miyu Okawa, Maho Miyamoto, Yuki Torii, Tomohiro Yamauchi, Junji FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator |
title | FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator |
title_full | FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator |
title_fullStr | FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator |
title_full_unstemmed | FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator |
title_short | FTD/ALS Type 7-Associated Thr104Asn Mutation of CHMP2B Blunts Neuronal Process Elongation, and Is Recovered by Knockdown of Arf4, the Golgi Stress Regulator |
title_sort | ftd/als type 7-associated thr104asn mutation of chmp2b blunts neuronal process elongation, and is recovered by knockdown of arf4, the golgi stress regulator |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443297/ https://www.ncbi.nlm.nih.gov/pubmed/37606396 http://dx.doi.org/10.3390/neurolint15030063 |
work_keys_str_mv | AT shirairemina ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator AT chomizuka ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator AT isogaimikinori ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator AT fukatsushoya ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator AT okabemiyu ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator AT okawamaho ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator AT miyamotoyuki ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator AT toriitomohiro ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator AT yamauchijunji ftdalstype7associatedthr104asnmutationofchmp2bbluntsneuronalprocesselongationandisrecoveredbyknockdownofarf4thegolgistressregulator |